Your browser doesn't support javascript.
loading
Development and Validation of a Chronic Kidney Disease Prediction Model for Type 2 Diabetes Mellitus in Thailand.
Tuntayothin, Wilailuck; Kerr, Stephen John; Boonyakrai, Chanchana; Udomkarnjananun, Suwasin; Chukaew, Sumitra; Sakulbumrungsil, Rungpetch.
Afiliação
  • Tuntayothin W; Department of Social and Administrative Pharmacy, Chulalongkorn University, Bangkok, Thailand.
  • Kerr SJ; Research Affairs, Chulalongkorn University, Bangkok, Thailand.
  • Boonyakrai C; Division of Nephrology, Department of Internal Medicine, Taksin Hospital, Bangkok, Thailand.
  • Udomkarnjananun S; Division of Nephrology, Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Chukaew S; Diabetes Center, Department of Internal Medicine, Taksin Hospital, Bangkok, Thailand.
  • Sakulbumrungsil R; Department of Social and Administrative Pharmacy, Chulalongkorn University, Bangkok, Thailand. Electronic address: rungpetch.c@pharm.chula.ac.th.
Value Health Reg Issues ; 24: 157-166, 2021 May.
Article em En | MEDLINE | ID: mdl-33662821
ABSTRACT

OBJECTIVES:

The objective of this study was to investigate predictors and develop risk equations for stage-3 chronic kidney disease (CKD) in Thai patients with type 2 diabetes mellitus (DM).

METHODS:

A retrospective cohort study was conducted in patients with type 2 DM. The outcome was the development of stage-3 CKD. The data set was randomly split into training and validation data sets. Cox proportional hazard regression was used for model development. Discrimination (Harrell's C statistic) and calibration (the Hosmer-Lemeshow chi-square test and survival probability curve) were applied to evaluate model performance.

RESULTS:

In total, 2178 type 2 DM patients without stage-3 CKD, visiting the hospital from January 1, 2008, to December 31, 2017, were recruited, with median follow-up time of 1.29 years (interquartile range, 0.5-2.5 years); 385 (17.68%) subjects had developed stage-3 CKD. The final predictors included age, male sex, urinary albumin to creatinine ratio, estimated glomerular filtration rate, and hemoglobin A1c. Two 3-year stage-3 CKD risk models, model 1 (laboratory model) and model 2 (simplified model), had the C statistic in validation data sets of 0.890 and 0.812, respectively.

CONCLUSIONS:

Two 3-year stage-3 CKD risk models were developed for Thai patients with type 2 DM. Both models have good discrimination and calibration. These stage-3 CKD prediction models could equip health providers with tools for clinical management and supporting patient education.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Insuficiência Renal Crônica Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article